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Abstract 
Numerous synthetic biomaterials have been de-
veloped as vascular substitutes. In vitro, ex vivo 
and in vivo studies have demonstrated that in ani-
mals , selected materials, i.e., Dacron and ePTFE 
(expanded polytetrafluoroethylene) grafts, are suc-
cessfully incorporated in both the large and the 
small caliber host arteries through a process which is 
generally referred to as graft healing. Morpholog-
ically, this process consists of a series of complex 
events including fibrin deposition and degradation, 
monocyte-macrophage recruitment and flow-oriented 
cell-layer generation, this last event being the 
complete endothelialization of the arterial substitute. 
In contrast to experimental animals, the flow 
surface of synthetic vascular grafts remains unhealed 
in humans, particularly in the small caliber conduits. 
Healing in man consists of graft incorporation by the 
perigraft fibrous tissue response with a surface cov-
ered by more or less compacted, cross-linked fibrin. 
It is therefore obvious that: i) marked differ-
ences in graft healing exist between animals and 
man; and ii) the usual mechanisms of graft endo-
thelialization are partially ineffective in man. 
In order to guarantee the patency of synthetic 
vascular grafts for human small artery bypass, new 
strategies and approaches have recently been at-
tempted. In particular, the endothelial cell seeding 
approach has been successfully accomplished in ani-
mals and is being experimented in human clinical 
studies. 
The problems and results of this biological 
approach are outlined in this paper. 
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Introduction 
The incorporation of synthetic vascular grafts 
in the host artery has been studied for a long time 
by many investigators (8, 71, 74, 76). Features sug-
gesting an efficient graft healing have been outlined 
(12, 13 , 19, 30, 62, 69, 74) . It was subsequently sug-
gested that a neointimal coverage on the implanted 
prosthetic material could significantly improve the 
clinical performance of high-flow and even more of 
low-flow small caliber grafts (7, 28, 79, 81). In par -
ticular, graft endothelialization is currently consi-
dered one of the essential factors influencing pat -
ency or occlusion of prosthetic grafts ( 7, 44, 81). 
However, the promising experimental results have not 
yet been confirmed in man (1, 7, 15, 24, 56, 76). 
This study deals with the healing of synthetic 
vascular grafts in animals and in humans. Particular 
attention will be paid to the recent techniques of 
seeding vascular grafts with endothelium. 
Spontaneous Graft Healing in Animals 
During the 1950s and early 1960s, Wesolowski 
(74, 77) screened more than 300 different materials 
in the growing pig and the adult dog. As a result of 
a number of observations, a relative scale of biologi-
cal acceptability was established, in which synthetic 
materials occupied an intermediate position. During 
the last few years, all but Dacron materials were re-
jected for different reasons. Thereafter , new bioma-
terials (e.g., expanded polytetrafluoroethylene, 
ePTFE) have been introduced. These are the only 
plastic materials used in large and small diameter 
grafts in humans. 
Dacron grafts 
Morphological studies have made it possible to 
define the basic pattern of Dacron healing and its 
eventual complications. Basically, Dacron heals 
through an early fibrinous incorporation which is 
gradually organized and converted into a tenacious 
and firmly adherent fibrous capsule (74, 77). 
The initial fibrin-implant complex is relatively 
stable and can remain essentially unchanged for 
weeks or even months, depending on the species of 
animal utilized. Interestingly, fibrin organization by 
granulation tissue requires a sufficient graft porosity 
(19, 30, 62, 77). 
From the beginning of its formation, the fibrin 
lining is continuously undergoing intense rearrange-
ments. The trapped leukocytes and particularly the 
macrophages phagocytize fragments of fibrin and cell 
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debris and release proteolytic enzymes which begin 
to digest the protein-rich luminal coverage. Concur-
rently, fibroblasts and small blood vessels proliferate 
and spread out through the graft interstices. In 
time, the entire fibrinous lining is converted into a 
well-vascularized connective tissue. Fibrous tissue 
contracts in the course of weeks to months. How-
ever, the grafts presents characteristic elasticity and 
compliance which is not adequate enough to balance 
the tensile strength generated by the normal scar 
contraction. Particularly at the level of the graft 
interstices, verification of a discrepancy between di-
verse tensile forces with consequent breakage and 
thrombosis of capillary channels may occur. This 
event may cause either a simple delay in the healing 
process or may even induce a band of necrosis, in 
areas where the healing phenomenon proves to be 
particularly intense, followed by calcification directly 
behind the prosthetic mesh. Complications of this 
nature, concerning the healing graft process desig-
nated by Wesolowsky (77, and also quoted by Weso-
low in 74) as inner capsule degeneration, is believed 
to be responsible for early graft failure, including 
perigraft seroma and hematoma and graft occlusion. 
The rate of healing complications is inversely related 
to graft porosity as described by the classic calcifi-
cation index curve from Wesolowski (77). 
Various authors have described endothelium on 
the inner side of the prostheses with both fibroblasts 
and smooth muscle cells forming the bulk of the un-
derlying intima. There is general agreement that 
graft endothelialization may originate from the host 
artery next to the suture lines (7). In contrast, 
other authors claim that endothelium may derive 
from capillary ingrowth into the graft interstices ( 12, 
13) as well as from a blood source (22, 46, 52, 59). 
In particular, Harker suggested that the endothelial 
lining might be generated by endothelial microemboli 
which may be present in the blood flow (26). More-
over, evidence of the transformation of mononuclear 
cells into myofibroblasts and endothelial cells was 
provided by Feigl et al. (18). 
Most probably there is a variable contribution 
of the different sources to the fully endothelialized 
grafts. In general, the host artery represents the 
most common source even though a kinetic study 
suggests that it is not very effective ( 5 7) . In the 
low porosity graft, a hyperplastic response develops 
on the part of the artery to which the graft is su -
tured. This reaction is called pannus (1) and slowly 
extends along the inner aspect of the prosthesis. By 
transmission electron microscopy (TEM), the pannus 
consists of undifferentiated mesenchymal cells, acti-
vated smooth muscle cells, fibroblasts and blood cells 
embedded in a loose extracellular matrix (Fig. 1). At 
surface level, the advancing edge of endothelial cells 
while migrating towards the fibrinous lining can be 
appreciated (48, 52). In the porous materials, the 
granulation tissue allows the formation of numerous 
blood vessels in the inner fibrinous aspect of the 
graft. The capillaries migrating through the inter-
stices of the prostheses can therefore provide multi-
ple sources of endothelium at the luminal surface 
(Fig. 2). 
ePTFE (expanded polytetrafluoroethylene) grafts 
ePTFE is a non-textile material which is hydro-
phobic at the time of insertion, gradually becomes 
wet, and within 48 to 72 hours becomes filled with 
fibrin and blood cells. The sequence of healing is 
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very similar to that of Dacron prosthese1 (8). 
However, the ingrowth of fibroblast and c<llagen 
tissue through the ePTFE pores proceeds more slowly 
than in Dacron because of the low porosity of the 
initially used materials. For the same reasm, the 
endothelialization of conventional ePTFE gr a lt s ( 30 
micrometers internodal distance) also proceed, very 
slowly. According to Clowes et al. (12), by 12 
months only 60 % of the grafts 6-9 cm in lengt1 were 
fully healed. Smooth muscle cells and endcthelial 
cells were provided from anastomotic arterial smrces. 
In a further study, Clowes et al. (13) provicbd the 
evidence that an increase in graft porosity (60 
micrometers internodal distance) can radicau, alter 
the mechanisms of ePTFE healing. By scanninf elec -
tron microscopy ( SE M), a confluent layer of endo-
thelial cells associated with multiple small capillary 
orifices was observed within 2 weeks of ePT fE im-
plantation, whereas a complete endothelial linbg was 
obtained after 4 weeks in baboons. In this ex:peri-
mental design, endothelium was provided by rapid 
transmural capillary ingrowth through the graf1 pores 
whereas smooth muscle cells most probably originated 
from pericytes surrounding endothelial cells. 
Compound prostheses 
Compound arterial prostheses represent he lat-
ter advance in the field of graft manufacturin&. As 
originally suggested by Wesolowski et al. (75) these 
prostheses are composed of two or more substances, 
where one of the components is readily resorbl.ble by 
the body and the other one remains permanen . The 
rationale for this design is to produce a material 
that has a low or zero porosity, a consequent mini-
mal controlled blood loss at implantation and a sig-
nificantly higher porosity, due to resorption of the 
biodegradable component at the time of the re::i.uired 
healing. Different combinations have been tested 
with varying results. 
Glutalardehyde- fixed albumin-coated Dacron 
grafts have a very low porosity (100 ml / min/ cm2 ) at 
implantation, but may be somewhat thrombogenic 
(25). Heat-denatured albumin-coated Dacron grafts 
produce better results. These materials have a 
smooth, homogeneous, well - fixed flow surface that is 
apparently thromboresistant. The heat - denatured 
albumin is resorbed within 4 weeks after imrlanta-
tion, and long - term healing is not affected (61). 
However, a delayed early tissue incorporation is 
reported and no immediate advantages besides the 
initial low porosity are evident. 
Wesolowski and associates screened nunerous 
grafts in which the biodegradable component was 
collagen (75). Most of these materials developed 
aneurysms and subsequent hemorrhage in animals. 
The same authors warned that these materials can 
interfere with graft healing and even accelerate graft 
occlusion (75). In contrast, Humphries et a:. (36) 
obtained encouraging results in dogs. Prostheses 
presealed with insoluble collagen were com;>letely 
organized by fibrous tissue within eight months of 
surgery. The pseudointima had replaced all but a 
few of the original bovine collagen fibrils and foci 
of endothelium were also observed. By comparing 
porous knitted grafts treated with insoluble collagen 
(cross-linked with glutaraldehyde) and presealed 
grafts in which collagen was cross-linked less 
strongly with formaldehyde , Jonas et al. ( 38 , 39) 
concluded that the delayed resorption of the sealant, 
because of excessive cross-linking, results in an 
Healing of Synthetic Grafts 
Fig .1. TE M of a knitted Dacron graft implanted 
in the sheep carotid seven days after implantation. 
At the anastomoses, the hyperplastic response is 
composed of undifferentiated mesenchymal cells 
(arrows), activated smooth muscle cells (arrowheads), 
fibroblasts (white arrows) and blood cells (bent 
arrows); bar = 5 micrometers. 
Fig. 2. SE M of a knitted Dacron graft implanted 
in the sheep carotid. After two months, the luminal 
opening of a neovascular channel is clearly observed. 
Note the continuity in the endothelial lining; bar = 
100 micrometers. 
Fig .3. SEM of a gelatin sealed knitted Dacron 
graft; bar = 100 micrometers. 
Fig .4. SEM (a) and TEM (b) of a gelatin sealed 
Dacron graft implanted in the sheep carotid. By 4 
months, the graft surface is evenly lined by endo-
thelial cells; bars a) = 50 micrometers, b) = 1 
micrometer. 
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undesirable lack of adhesion between the pseudo-
intima and the luminal surface of the prosthesis. 
This may generate early graft failure due to large 
areas of hemorrhagic dissection. 
Heat-denatured forms of collagen, namely gela-
tin, have been proposed for precoating Dacron knit-
ted grafts (Fig. 3). Jonas et al. (40) reported that 
after 6 months both rat subcutaneous and canine cir-
culatory implants reveal rapid and complete gelatin 
adsorption without undesirable modification of the 
normal healing process of knitted Dacron. In our 
experience gelatin sealed knitted Dacron grafts are 
also suitable as small caliber arterial substitutes 
(52). Sixteen grafts (knitted Dacron Triaxial, 8; 
knitted Gelseal, 8) of 6 mm diameter were inserted 
with end to end anastomoses into both the common 
carotid arteries of 8 young sheep. Multiple speci-
mens (distal and proximal anastomoses, central por-
tion of the graft) were retrieved at 1, 2, 8 and 16 
weeks after surgery. The combined light and elec-
tron microscopic (TEM and SEM) investigation along 
with the immunogold labelling technique clearly dem -
onstrated that bovine gelatin impregnation did not 
interfere with the neointima generation. Gelatin was 
reabsorbed within 2 weeks of surgery. A well-devel-
oped and thin pseudointima, composed of modified 
smooth muscle cells and fibroblasts embedded in a 
loose extracellular matrix, was observed eight weeks 
after implantation. By 4 months, Gelseal grafts were 
evenly lined by endothelial cells (Fig. 4a, b) placed 
on layers of mainly synthetic smooth muscle cells 
(Fig. 5) as well as myofibroblasts. In this experi-
mental design, endothelial cells were mainly provided 
by sources at the cut edge of the host arteries. No 
significant local inflammatory reaction was encoun -
tered in the Gelseal Dacron grafts. In contrast, the 
contralateral knitted Dacron without gelatin impreg-
nation failed to develop a complete neointimal cover -
age. Myofibroblasts and fibroblasts were the domi-
nant cells covering these synthetic grafts. It was 
therefore concluded that gelatin impregnation was 
also useful in promoting the healing process. 
Bowald et al. (3, 4) used Vicryl 910 as the 
biodegradable component. Vicryl is a copolymer 
consisting of 90% polyglycolic acid and 10% polylactic 
acid. Bowald placed a mesh of Vycril 910 into a 
Dacron graft. Four-cm grafts implanted in the aorta 
of pigs were endothelialized within 20 days and by 
40 days the Vicryl mesh had virtually disappeared. 
Spontaneous Graft Healing in Humans 
For perhaps as long as 20 years, spontaneous 
endothelialization of synthetic grafts, as previously 
described in animals, was assumed to occur in 
humans (7). DeBakey and associates (15) observed 
the healing features of 67 patent prostheses re-
covered from man following implant periods of 2 
weeks to almost 7 years. Most of the grafts failed 
to organize the inner fibrinous capsule since their 
surface appeared homogenously covered by fibrin. In 
contrast, endothelium was believed to occur in some 
specimens. 
In 1964 Wesolowoski (76) stated that "unlike the 
pig and the dog, the human does not heal the inner 
capsule completely prior to the onset of intercapsular 
tuft degeneration". In accordance with this state-
ment, Berger et al. clearly demonstrated graft failure 
to develop any endothelial coverage in man (1). Dif-
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ferent arterial grafts of varying degrees of porosity 
were compared (woven, knitted, light and extra light 
knitted Dacron). In no instance was there evidence 
of endothelium on the inside of the materials, except 
within 10 mm of the suture lines. 
In a detailed study, Sottiurai et al. (68) re-
ported a complete pseudointimal lining on Dacron 
grafts (both woven and knitted) removed en bloc 
during reoperation or amputation. The pseudointima 
consisted of fibroblastoid cells orientated parallel to 
the direction of the blood flow. The cells were em -
bedded in a loose extracellular matrix composed of 
collagen fibres and amorphous ground substances. In 
contrast, ePTFE lacked any organized form of cellu -
lar coverage, being largely covered by acellular 
fibrinous material. Deposition of fibrin on ePTFE 
was also reported by Walton et al. (73). Fibrinous 
materials within the graft pores appeared, gradually 
converted into granulation tissue and later into 
fibrous tissue. 
Our obser.rations agree with the previous re-
ports (1, 24, 45, 56, 62, 68, 70). Both Dacron and 
ePTFE grafts showed a particular form of healing in 
humans. This generally consists of the deposition of 
proteinaceous materials on the graft surface. This 
material organizes giving origin to a continuous sheet 
of fibrin in conjunction with blood cells (Fig. 6). 
This lining represents the major kind of lining we 
observed in humans. In some instances, a capillary 
ingrowth was evident in the inner fibrin capsule. 
SEM made it possible to demonstrate the surface ori-
fices of the vascular channels in ePTFE grafts next 
to the anastomoses (Fig. 7). In contrast with ani-
mals, endothelial cells provided by this transmural 
source failed to migrate into the surrounding fibrin 
mesh except for a few mm. At anastomotic level, a 
host cellular reaction (i.e., pannus) composed of myo-
fibroblasts, undifferentiated mesenchymal cells, blood 
cells and extracellular matrix was observed. The 
pannus growth always had a limited extension to-
wards the graft plane. In addition, a ring - like area 
of intimal thickening was frequently encountered es-
pecially at the downstream anastomosis. By LM and 
TEM, the bulk of the lesion was composed of vari-
ously-arranged spindle smooth muscle cells with a 
synthetic phenotype. The cells, focally showing a 
whorled-liked appearance rest on a loose extracellu -
lar matrix containing proteoglycans and collagen 
fibers. Collagen showed great variability in width 
and shape and in some instances displayed a moth-
eaten appearance. 
Endothelial Seeding in Animals 
For more than a decade, endothelial seeding has 
been understood as the preparation of vascular pros-
theses by seeding with endothelial cells taken from 
other vascular districts. The first experiment was 
carried out by Herring (28), who in 1978 described 
the possibility of obtaining endothelial cells by 
mechanical scarification of the saphena intima and 
then seeding these cells on Dacron prostheses. 
These prostheses, implanted in dogs, were compared 
with control, unseeded prostheses after 2, 4 and 8 
weeks. The results emphasized the minor thrombo-
genicity and minor thickness of the neointima of the 
seeded prostheses as compared to the control pros-
theses. 
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Fig. 5. TE M of a gelatin sealed Dacron graft 
implanted in the sheep carotid. Four months after 
implantation, the synthetic smooth muscle cells are 
the major cell component of the neointima; bar = 2 
micrometers. 
Fig.6. SEM of a human ePTFE femoral popliteal 
bypass. After 21 months, the surface is still coated 
with fibrin, erythrocytes, and leukocytes. Note the 
adhesion (arrows) of endothelial or pseudoendothelial 
cells to the underlying macrophages; bar = 10 micro-
meters. 
Fig. 7. SEM of a human ePTFE femoral popliteal 
bypass. After 6 months, the transmural capillaries 
fails to provide endothelial cells; bar = 300 micro-
meters. 
Fig. 8. TE M of collagenase harvested human 
fat-derived microvessel endothelial cells. The cells 
are still clustered by tight junctions (arrow). 
Weibel-Palade bodies are clearly observed (arrow-
head); bar = 2 micrometers. 
Fig .9. SEM of enzymatically harvested human 
mesothelial cells. The cells are spreaded onto a 
fibronectin-coated glass surface; bar = 10 micro-
meters. 
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As an alternative to the so-called mechanically 
harvested endothelium, Graham, in 1980, proposed the 
enzymatic derived endothelium technique (20), which 
allows the detachment of the endothelial cells from 
the vessel wall by successive enzymatic washings 
with trypsin and/or collagenase. This method was 
shown to be effective both as regards quality and 
quantity and it established itself as the technique of 
choice. Subsequent modifications were made to this 
technique by Sharefkin (64) and Bourke (2). 
As an alternative to the medium -large sized 
veins which were originally used as a source of 
endothelial cells (21, 28, 31, 35), Williams et al. (78, 
79) proposed the extraction of endothelial cells from 
the microcirculation of the adipose tissue (Fig. 8). 
In addition, Clarke and Pitillo (10, 11) demonstrated 
that mesothelial cells (Fig. 9) extracted from dog 
omentum have the capacity to form a functional, 
non-thrombogenic lining for prosthetic grafts. 
The identification of the endothelial cells was 
made possible by observing Weibel-Palade bodies at 
transmission electron microscopic level or using im -
munofluorescent staining for Factor VIII-related anti-
gen (7, 28, 78, 79). The immuno-gold labelling ap-
proach for detecting the Factor VIII-related antigen, 
the glycoprotein Ilb /Illa, moieties for the 1-fucose 
and cytoskeletal antigens (i.e., actin, vimentin) was 
also used at ultrastructural level (14). 
Another important aspect is the quantity of 
endothelial cells which can be collected from the 
donor tissue for an adequate lining of the prosthesis. 
Herring (29) calculated that the maximum quantity of 
endothelial cell harvest is 25xlo4 cells/cm2 of vein. 
McCall saw that a minimum cell density of 2 .5x104 
cells/cm2 was necessary to develop a confluent 
growth of pig aorta endothelial culture on ePTFE 
membrane, after 5 days (47). 
On the other hand, Rosenman (60) claims that 
endothelial cell growth in culture is essential for 
successful seeding. Using culture media with endo-
thelial cell-derived growth factor and heparin, Jarrel 
(37) succeeded in producing 1000 cm2 of confluent 
endothelial cells in 12 days from one cm2 of vessel 
wall. This permitted the seeding of vascular pros-
theses with high density of endothelial cells. 
Burkel (5) stressed the importance of morpho-
logical investigation to evaluate the success of 
seeding. He studied Dacron prostheses in dog, mak-
ing observations between the first and twenty-
eighth day after implant. There is no difference be-
tween the seeded and control prostheses immediately 
after the clot. The prostheses are completely in-
filtrated with fibrin and blood cells. After one day 
the prostheses are covered by a layer of activated 
platelets and leukocytes. A few endothelial cells can 
be seen between the threads of the seeded prosthe-
ses. A differentiation between the control and 
seeded prostheses becomes visible after 4 days. In 
the seeded grafts these are patches of immature 
endothelial cells without a basal lamina but resting 
on a layer of fibrin. After 7 days the control pros-
theses continue to be covered with fibrin, platelets 
and leukocytes. In contrast, the seeded prostheses 
show patches of endothelial cells with distinct junc -
tions and lysis of the subendothelial fibrin mesh. 
Clear differences can be seen after 14 days when, in 
the control prostheses, 75% of the lumen is occupied 
by thrombotic material of varying thicknesses. On 
the contrary, the seeded prostheses appear to be al-
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most completely free from thrombus and 60% of the 
surface is lined with endothelium, below which 
smooth muscle cells and fibroblasts can be seen. In 
some parts, the prostheses appear to be completely 
encorporated by a fibrous capsule. On the outside 
foreign body giant cells can be seen, together with 
dense connective tissue and numerous capillaries. 
After 28 days post-implantation the seeded prostheses 
are 80% lined with endothelium as compared to 10% 
in the control prostheses. 
In the seeded grafts the endothelial cells have 
junctional complexes and basal lamina. The subendo-
thelial connective tissue consists of smooth muscle 
cells, collagen and fibroblasts. Vessels can be 
clearly seen, penetrating through the prosthetic wall. 
Basically, whereas in the control prostheses there is 
a simple reorganization of the fibrin clot and a peri-
anastomotic endothelialization, in the seeded prosthe-
ses, besides an almost complete endothelialization, a 
subendothelial layer is formed, consisting of smooth 
muscle cells. These observations were also confirmed 
in other experimental models (6, 66). 
The morphological data are flanked by a whole 
series of functional studies on the efficacy of endo-
thelial seeding which improves the survival of plate-
lets and decreases the release of platelet serotonin 
(7, 9, 23). Moreover, the endothelial cells maintain 
the capacity for prostacycline synthesis (23, 65). 
Following the first experiments using Dacron 
protheses, the possibility of treating ePTFE with 
endothelial seeding was also examined. Graham, in 
1982, in a dog model, seeded ePTFE prostheses 6-10 
mm in diameter and 20-30 mm long with endothelial 
cells (21). In this case also, endothelialization by 
seeding appeared to be more rapid and complete than 
unseeded prostheses. Indeed, after 4 weeks, 91% of 
the surface of seeded prostheses was lined with 
endothelial cells, whereas in the control prostheses 
endothelialization did not arrive at more than 7 mm 
from the anastomoses. In addition, Graham observed 
some peculiar differences between the healing of 
seeded ePTFE and seeded Dacron. ePTFE, indeed, 
appeared to be less reactive to blood components. 
The inner capsule appears to be thinner, and there is 
less infiltration and incorporation by the leukocytes. 
One characteristic feature observed was that in 
seeded ePTFE the endothelial monolayer was not reg -
ularly supported by a subendothelial tissue; in par -
ticular, unlike seeded Dacron, no smooth muscle cells 
were observed. These differences can be attributed 
to the differences in the chemical structure, in con-
figuration and above all in the permeability of 
Dacron and ePTFE. In addition, Miller et al. (49) 
demonstrated that although both Dacron and ePTFE 
were efficient in the macrophage activation, Dacron 
surface had a greater density of activated cells cor-
responding to elevated levels of interleukin-! in 
cultures. 
Herring (32) compared the two types of pros-
theses with controls after 7 months and confirmed 
the good endothelialization capacity of seeded ePTFE, 
which appeared to be more rapid than in seeded 
Dacron. The importance was emphasized of the thin-
ner inner capsule in ePTFE as compared to Dacron 
(22 ± 32 micrometers vs 169 ± 143 micrometers). 
This depends in particular on the low porosity of 
ePTFE (internodal distance 30 micrometers) which 
hinders the transparietal diffusion of cellular ele-
ments (myofibroblasts and smooth muscle cells) and 
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the formation of vasa vasorum. Herring attributed 
the minor tendency of seeded ePTFE to develop a 
myointimal hyperplasia to these characteristics. 
According to other authors ( 41), the absence of 
a subendothelial structure does not favour a stable 
and well functioning endothelium ; it is thus suggested 
that ePTFE prostheses with a greater porosity should 
be used (internodal distance 45 micrometers). 
Although the results reported are encouraging, 
Hollier (35) raises doubts as to the origin of the 
endothelial lining in seeded protheses. He made a 
study in male pigs, seeding prostheses with endo-
thelial cells collected from female pigs. After 4 
weeks the implanted prostheses appeared to be lined 
with endothelial cells with male karyotype, thus 
excluding successful seeding. 
The possibility of staining the seeded endo-
thelial cells with indiumlll was explored by 
Rosen man ( 60), with the intention of quantifying 
over time the presence of cells seeded on a vascular 
prosthesis once the blood flow had been re-estab-
lished. The result was that after 24 hours only a 
small part of the seeded endothelial cells were pre-
sent on the prosthesis. In the first thirty minutes 
after restoration of blood flow there is a rapid loss 
of endothelial cells. This is followed by a stage, 
from 30 minutes to 24 hours, in which the endothe-
lial cells are lost at a slower but constant rate so 
that at 24 hours only 17% of the endothelial cells 
adhering at the beginning remains. However, 
Patterson et al. (53) demonstrated the spontaneous 
loss of indiumlll from isolated canine endothelial 
cells. It was therefore suggested that indiumlll 
oxine labeling is not a reliable technique for the 
study of endothelial cell kinetics in vivo. Recently, 
some authors (50, 80) used recombinant retroviruses 
to transduce beta- galactosidase genes into harvested 
endothelial cells. This technology appears particular-
ly suitable in order to estimate the presence of 
seeded endothelial cells on vascular substrates. 
A problem thus emerges of great importance for 
the success of seeding: how to improve the adhesion 
of the seeded endothelial cells to the prosthetic 
material. 
In the first place, several methods of endothe-
lial seeding have been proposed to improve seeding 
efficacy. Kesler ( 43) suggested sequential inocula-
tion; Faso! (17), uses a rotation device; Shindo (67) 
seeds the endothelial cells on prostheses in a glass-
ware apparatus for 48-72 hours before implanting. 
At the same time, research in the field of pros-
thetic substratum has been developed. The precoat-
ing of material with fibronectin has been shown to 
be very effective, starting with the first experiments 
by Kempczinski and Ramalanjaona (42, 55). This 
method increases the adhesion of the seeded endo-
thelia l cells, reducing their loss once blood flow has 
been restored. 
Our approach was designed to analyze the in-
teraction between endothelial cells and various syn-
thetic vascular grafts by means of SEM (14). Endo-
thelial cells were harvested from adipose tissue by 
using collagenase treatment. Cell viability, as deter-
mined by Trypan Blue exclusion, resulted in higher 
than 90% of isolated cells. Endothelium was charac-
terized by the demonstration of positivity for Factor 
VIII-related antigen and glycoprotein lib/Illa. Endo-
thelial cells were seeded and left to adhere for one 
hour onto different synthetic grafts. As expected, 
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knitted Dacron and ePTFE alone are not suitable for 
generating endothelial cell monolayers. In fact, SEM 
showed no cell adhesion on these substrates. Blood 
preclotting did not significantly improve the rate of 
c ell adhesions and basically resulted in the presence 
of areas with cell attachments. Commercially availa-
ble coated grafts (Gelseal Dacron, Albumin-coated-
Dacron, Hemashield Dacron) were further investi-
gated. Interesting results were obtained with gela-
tin-coated Dacron (Gel seal). In agreement with 
other authors (27), we found that gelatin permits the 
adhesion of seeded endothelium. A high density of 
adherent endothelial cells was seen on the Gelseal 
surface even though the rate of cell spreading was 
low (Fig. 10). Adherent cells were mainly round in 
shape. However, many cells showed thin filopodia 
while others exhibited complex surface corrugations. 
A few spread cells were also found. In our experi-
ments these results were not constant; this most 
likely depends on variations in the physico-chemical 
characteristics of the gelatin contained in different 
industrial supplies (14). In contrast, Albumin-coated-
Dacron and Hemashield Dacron (sealed with type I 
collagen) did not seem to favor endothelial cell 
adhesion. In particular, Albumin-coated grafts lacked 
endothelial coverage while Hemashield Dacron showed 
an intermediate behavior. By SEM, clusters of endo-
thelium were observed particularly in the hollows of 
the material. These results do not comply with 
those reported in experimental models ( 54) and in 
animal models (67) utilizing collagen-coated-Dacron. 
However, this discrepancy could be attributed to the 
fact that Shindo et al. (67) impregnated their pros-
theses with a mixture of 1/111 type collagen. In our 
experience, the best results are provided by adsorbed 
ePTFE grafts with bioactive molecules. As previously 
described, ePTFE alone did not permit any cell adhe-
sion. However, incubation of ePTFE with 20 mg/cm2 
of fibronectin for 2 hours at 37°C resulted in a 
dense lining of seeded endothelial cells (20-29 cells/ 
micrometers2) with a significant tendency to spread 
out (Fig. 11). The exposure of endothelial cells to 
this substrate induced rapid cell morphological 
changes. Endothelium lost their round appearance 
and extended long, slender filopodia making tenuous 
contacts with the substrate. As the endothelial ad-
hesion proceeded, the interaction appeared more sta-
ble. Endothelial cells presented peripheral cyto-
plasmic flaps and in some areas completely spread 
over the substrate. Analogous results were provided 
by ePTFE grafts preliminary treated with fibrin-con-
taining mixtures. SEM examination of fibrin glue 
(Immuno AG) coated ePTFE grafts clearly revealed a 
sharp transition in cell adhesion between coated and 
uncoated ePTFE surfaces (Fig. 12) thus confirming 
data provided by Zilla et al. (82). 
Finally, the experiments carried out with car-
bon-coated ePTFE (63) should also be kept in mind. 
Endothelial Seeding in Man 
The first experiments of endothelial seeding in 
man were carried out by Herring (31), who in 1984 
reported the results of a trial with implanting of 
Dacron prostheses seeded with endothelial cells col-
lected with the mechanical method. The data con-
cern bypasses made in different vascular areas: 
axillo-femoral, femoro-femoral and femoro-popliteal; 
in this last group the seeded prostheses are also 
G. Pasquinelli, et al. 
358 
Fig. 10. SEM of collagenase harvested human 
fat-derived microvessel endothelial cells. After 1 h 
of incubation on a gelatin coated Dacron graft, the 
density of cell adhesion is high; bar == 100 micro-
meters. 
Fig. 11. SE M of collagenase harvested human 
fat-derived microvessel endothelial cells. After one 
hour of incubation on a fibronectin-coated ePTFE 
graft, there is a good cell adhesion on the substrate. 
Spread endothelial cell are also present; bar == 50 
micrometers. 
Fig.12. SEM of collagenase harvested human 
fat-derived microvessel endothelial cells. After 1 h 
of incubation on a fibrin glue coated ePTFE graft, 
there is a sharp transition in cell density between 
coated and uncoated PTFE surface; bar == 25 micro-
meters. 
compared with the autologous vein. The results as-
sessed on the basis of the patency and the platelet 
function, are not the same as those obtained in ex-
periments performed in animals. Although he reports 
an improved patency in seeded prostheses of some 
sub-groups (femoro-popliteal of non-smokers), 
Herring did not, in fact, observe great differences 
between seeded and control prostheses. He did, 
however, confirm the validity of the autologous vein. 
The small number of histological observations did not 
reveal seeded endothelial cells on the prostheses 
after 4 months, but only fibroblasts and smooth 
muscle cells. 
It was Herring again, who made an interesting 
morphological observation of seeded ePTFE at 90 
days after implant in man (33). Unlike the experi-
ence with Dacron, areas of endothelialization could 
be recognized in this case, characterized by a mono-
layer of endothelium-like cells, resting on a thin 
layer of matrix with no elastin, collagen or smooth 
muscle cells. Given the distance from the anastomo-
sis of the area examined (10 cm) and the absence of 
myofibroblasts, Herring concludes that endothelializa-
tion is probably secondary to seeding. 
In 1986 in Vienna, the results were presented 
of 4 clinical trials carried out in different centres: 
Indianapolis, Vienna, Goteborg and Dundee (17, 34, 
58, 72). Although there were a few differences due 
to the harvesting and seeding techniques employed, 
the prosthetic material used and the postoperative 
control methods, the various authors concluded that 
endothelial seeding in man gives less positive results 
than in animals. Although, on the basis of long-term 
patency and platelet reactivity, the comparison be -
tween seeded and control protheses appears to indi-
cate the major healing characteristics of seeded 
prostheses; the comparison of data does not reveal 
statistically significant differences. 
Discussion 
Several groups of investigators have described 
the clinical and experimental results of graft in-
corporation using synthetic materials of various de-
signs and compositions (7, 62, 71, 74, 77, 81). Some 
reports have also provided detailed and correlated 
documentation of the arterial cellular and subcellular 
healing responses to graft implants in animals ( 12 , 
13, 54, 56, 59, 70, 77). Most of these papers support 
the view that synthetic vascular grafts of both 
Dacron and ePTFE fabrics heal through a process of 
Healing of Synthetic Grafts 
graft arterialization which, within certain limits, 
seems to recapitulate the normal architecture of the 
replaced artery. At the final stage, a continuous 
luminal graft repopulation with endothelial cells 
and/or modified smooth muscle cells (neointima) 
takes place. As far as graft thrombogenicity is 
concerned, this neointimal coverage represents the 
ideal blood/graft interface (7, 44, 79). 
In contrast to experimental animals, the flow 
surface of both Dacron and ePTFE grafts in humans 
remains unhealed, with a surface of more or less 
compacted, cross-linked fibrin. Healing in humans 
consists of outer wall attachment by fibrous tissue. 
Further healing of the prosthesis occurs very slowly 
and rarely involves the inner wall. This consists of 
a thin and relatively stable fibrin lining due to a 
critical equilibrium between fibrin neo-deposition and 
its degradation by the monocyte/macrophage system. 
In addition , endothelium and smooth muscle cells 
provided from the arterial sources (anastomoses) mi-
grate only a few mm from the cut edge of the artery 
(1, 15, 76). Patches of cell coverage most likely 
related to the graft capillarization remain circum-
scribed to the luminal openings of the neointimal 
c apillaries mainly at the anastomoses and the cells 
provided do not extend any further. Therefore, the 
usual patterns of graft endothelialization seem to be 
ineffective in man. In any case, the luminal fibrin 
coverage remains essentially unchanged for months or 
even years and appears as a relatively non -thrombo-
genic lining. In the large conduits, in fact, this 
lining seems to be sufficient to minimize graft com -
plication. In fact, the patency rate of Dacron and 
ePTFE grafts is particularly high in the aorto- iliac 
position. However, with diameters of 5 mm or less 
the failure rate of both these materials is unaccept-
able. After 3 months, approximately 30 % of the 
grafts are closed by early thrombosis. After 36 
months, only 20 % of artificial grafts are still patent 
(7). In this context one of the causes of the lack of 
success of artificial prostheses when compared to 
autologous vein implants, besides the evident differ-
ence in compliance, may be attributed to the lack of 
functioning endothelium at the moment of implant. 
Therefore, the presence of a continous endothelial 
layer should be considered as an essential prerequi-
site for the success of low -flow, small-diameter 
grafts. 
The need to favour a rapid and, as far as pos-
sible, complete endothelialization of implanted vas-
cular prostheses has induced some researchers to in-
troduce and develop the endothelial seeding technique 
(28, 79). The experiments carried out, with various 
prosthetic materials in animal, are without doubt 
encouraging. From a clinical point of view, seeded 
prostheses give immediate patency results and, in the 
long run, better results than unseeded prostheses. 
From a functional point of view, there is a more ef-
fective restoration of the synthetic endothelial ac -
tivity as well as an improvement in the main platelet 
functioning parameters in seeded prostheses. In 
addition, seeding permits an almost complete and 
rapid endothelialization of the prosthesis segment 
with different aspects linked to the chemico-physical 
and structural characteristics of the various materials 
studied. The results obtained with endothelial seed-
ing in animals indicate that although the actual ca-
pacity of seeded endothelial cells to remain attached 
to the prostheses, subject to hemodynamic stress, has 
not been clearly established; this method does favour 
prosthetic endothelialization. 
Equivalent results have not been obtained in 
the few experiments carried out in man. It may be 
postulated that there are many causes which inter-
fere with the efficacy of endothelial seeding in man. 
In the first place, the difficulty of harvesting a 
sufficient number of endothelial cells must be consi-
dered. To this can be added the need to overcome 
the limitations involved in using human endothelial 
cultures and the need to find substratum which fa-
vour a major adhesion of seeded endothelial cells. 
In the second place, along with the well-known dif-
ferences between species (16), it should be remem-
bered that in a man requiring a prosthetic implant, a 
multidistrict steno-obstructive disease is present, 
inducing complex variations in the regional hemody-
namics. This disease is also maintained and aggra-
vated (70, 73) by the presence of various factors 
such as smoking, diabetes, hypertension and hyper-
lipidemia. 
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In conclusion, the thirty years of experiments 
in the field of synthetic vascular prostheses have 
revealed large differences in the results in animal 
models and those in human models. In man, while in 
the aorto-iliaco- femoral district a fibrin layer ap-
pears to be sufficient for long-term patency of such 
materials; in small caliber districts an improvement in 
compliance and an endothelial lining is essential. 
This may be favoured by endothelial seeding. Some 
encouraging results in man have been achieved with 
this method. The long-term fate of seeded grafts in 
man, however, can only be assessed with an increase 
in clinical experiences together with the use of more 
sophisticated morphological and functional analyses. 
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Discussion with Reviewers 
K.A. Robinson: What are your criteria for the char-
acterization of syntjetic smooth muscle cells and 
their distinction from myofibroblasts at the TE M 
level? Clowes et al. (13) have shown that, at least 
in ePTFE grafts, the spindle-shaped cells of the neo-
intima were all smooth muscle cells. This may have 
significance in terms of extracellular matrix produc -
tion and any retraction of the intimal thickening. 
Authors: According to F. N. Ghadially (Diagnostic 
Electron Microscopy of Tumours, Ilnd edition, 
Butterworths, London, 1985, pp. 456 - 466.), the 
following TEM features were used to distinguish 
myofibroblasts from synthetic smooth muscle cells: i) 
abundance of elements of the Golgi complex and 
rough endoplasmic reticulum; ii) paucity of micro-
pinocytotic vesicles; and iii) absence or relative 
infrequency of basal-lamina- like material. 
K.A. Robinson: You cite recent work regarding adi-
pose tissue as a source of endothelial cells from 
graft seeding. What are the advantages of this tech-
nique, particularly with respect to cell yield and 
seeded cell density? 
Authors: The major advantages of this technique 
are: 1) large quantity of endothelial cells are rapidly 
(2-4 hr) available (average yield: 104-106 cells/g fat 
tissue); ii) reproducibility in yield; iii) high endo-
thelial cell yield for immediate monolayer generation; 
and iv) large vessels for cell procurement are spared. 
K.A. Robinson: Could the divergent healing re-
sponses of experimental animals and humans be due 
in part to discrepance in relative age? Perhaps a 
greater regenerative capacity is seen in the former 
because relatively young animals are used. 
Authors: Yes, we agree with your comment. 
K .A. Robinson: Another possible reason for graft 
failure may be cytokine stress from adherent leuko-
cyte (Fig. 6). Could you comment on the role of 
chronic inflammation in graft failure? 
Authors: Interleukin - 1 (IL - 1) and tumor necrosis 
factor (TNF) are important cytokines produced by 
activated mononuclear cells. They share many bio-
logic properties and also act synergistically. In 
particular, IL-1 and TNF produce local effects on 
endothelium which may be relevant to the process of 
graft failure. IL-1 and TNF induce on endothelium 
the synthesis of surface adhesion molecules, which 
stimulate increased adhesion of inflammatory cells to 
the endothelium. They stimulate the endothelial cell 
synthesis of platelet activating factor, which is a 
powerful platelet activator and aggregator. They 
produce an increase in procoagulant and a decrease 
in anticoagulant properties of endothelial cells, ren-
dering the endothelial surface potentially thrombo-
genic. 
